0001288469December 312020Q1false0.00010.000125,00025,0000.00010.0001550,000550,00072,34571,54972,34571,5499141130nononono35251520.40.3212.00.10.3noP3Y00012884692020-01-012020-03-310001288469exch:XNYS2020-01-012020-03-31xbrli:shares00012884692020-04-22iso4217:USDxbrli:sharesiso4217:USD00012884692020-03-3100012884692019-12-3100012884692019-01-012019-03-310001288469us-gaap:CommonStockMember2019-12-310001288469us-gaap:AdditionalPaidInCapitalMember2019-12-310001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001288469mxl:AccumulatedDeficitMember2019-12-310001288469us-gaap:CommonStockMember2020-01-012020-03-310001288469us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310001288469mxl:AccumulatedDeficitMember2020-01-012020-03-310001288469us-gaap:CommonStockMember2020-03-310001288469us-gaap:AdditionalPaidInCapitalMember2020-03-310001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001288469mxl:AccumulatedDeficitMember2020-03-310001288469us-gaap:CommonStockMember2018-12-310001288469us-gaap:AdditionalPaidInCapitalMember2018-12-310001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310001288469mxl:AccumulatedDeficitMember2018-12-3100012884692018-12-310001288469us-gaap:CommonStockMember2019-01-012019-03-310001288469us-gaap:AdditionalPaidInCapitalMember2019-01-012019-03-310001288469mxl:AccumulatedDeficitMember2019-01-012019-03-310001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-03-310001288469us-gaap:CommonStockMember2019-03-310001288469us-gaap:AdditionalPaidInCapitalMember2019-03-310001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-03-310001288469mxl:AccumulatedDeficitMember2019-03-3100012884692019-03-310001288469us-gaap:OneTimeTerminationBenefitsMember2020-01-012020-03-310001288469us-gaap:OneTimeTerminationBenefitsMember2019-01-012019-03-310001288469us-gaap:FacilityClosingMember2020-01-012020-03-310001288469us-gaap:FacilityClosingMember2019-01-012019-03-310001288469us-gaap:OtherRestructuringMember2020-01-012020-03-310001288469us-gaap:OtherRestructuringMember2019-01-012019-03-310001288469mxl:TerminatedLeaseDomain2019-01-012019-03-310001288469us-gaap:OneTimeTerminationBenefitsMember2019-12-310001288469us-gaap:FacilityClosingMember2019-12-310001288469us-gaap:OtherRestructuringMember2019-12-310001288469mxl:LeaseRelatedImpairmentMember2020-01-012020-03-310001288469us-gaap:OneTimeTerminationBenefitsMember2020-03-310001288469us-gaap:FacilityClosingMember2020-03-310001288469us-gaap:OtherRestructuringMember2020-03-310001288469mxl:RestructuringShorttermDomainus-gaap:OneTimeTerminationBenefitsMember2020-03-310001288469mxl:RestructuringShorttermDomainus-gaap:FacilityClosingMember2020-03-310001288469mxl:RestructuringShorttermDomainus-gaap:OtherRestructuringMember2020-03-310001288469mxl:RestructuringShorttermDomain2020-03-310001288469mxl:RestructuringLongtermDomainus-gaap:OneTimeTerminationBenefitsMember2020-03-310001288469us-gaap:FacilityClosingMembermxl:RestructuringLongtermDomain2020-03-310001288469us-gaap:OtherRestructuringMembermxl:RestructuringLongtermDomain2020-03-310001288469mxl:RestructuringLongtermDomain2020-03-310001288469mxl:LicensedTechnologyMember2020-01-012020-03-310001288469mxl:LicensedTechnologyMember2020-03-310001288469mxl:LicensedTechnologyMember2019-12-310001288469us-gaap:DevelopedTechnologyRightsMember2020-01-012020-03-310001288469us-gaap:DevelopedTechnologyRightsMember2020-03-310001288469us-gaap:DevelopedTechnologyRightsMember2019-12-310001288469us-gaap:TrademarksAndTradeNamesMember2020-01-012020-03-310001288469us-gaap:TrademarksAndTradeNamesMember2020-03-310001288469us-gaap:TrademarksAndTradeNamesMember2019-12-310001288469us-gaap:CustomerRelationshipsMember2020-01-012020-03-310001288469us-gaap:CustomerRelationshipsMember2020-03-310001288469us-gaap:CustomerRelationshipsMember2019-12-310001288469us-gaap:NoncompeteAgreementsMember2020-01-012020-03-310001288469us-gaap:NoncompeteAgreementsMember2020-03-310001288469us-gaap:NoncompeteAgreementsMember2019-12-310001288469us-gaap:CostOfSalesMember2020-01-012020-03-310001288469us-gaap:CostOfSalesMember2019-01-012019-03-310001288469us-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-03-310001288469us-gaap:ResearchAndDevelopmentExpenseMember2019-01-012019-03-310001288469us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-03-310001288469us-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-03-310001288469us-gaap:FairValueInputsLevel2Member2020-03-310001288469us-gaap:FairValueInputsLevel2Member2019-12-310001288469us-gaap:FurnitureAndFixturesMember2020-01-012020-03-310001288469us-gaap:FurnitureAndFixturesMember2020-03-310001288469us-gaap:FurnitureAndFixturesMember2019-12-310001288469us-gaap:MachineryAndEquipmentMember2020-03-310001288469us-gaap:MachineryAndEquipmentMember2019-12-310001288469mxl:MasksAndProductionEquipmentMember2020-03-310001288469mxl:MasksAndProductionEquipmentMember2019-12-310001288469us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2020-01-012020-03-310001288469us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2020-03-310001288469us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2019-12-310001288469us-gaap:LeaseholdImprovementsMember2020-03-310001288469us-gaap:LeaseholdImprovementsMember2019-12-310001288469us-gaap:ConstructionInProgressMember2020-03-310001288469us-gaap:ConstructionInProgressMember2019-12-310001288469mxl:ReductioninTransactionPriceMember2020-03-310001288469mxl:ReductioninTransactionPriceMember2019-12-310001288469us-gaap:SalesReturnsAndAllowancesMember2020-03-310001288469us-gaap:SalesReturnsAndAllowancesMember2019-12-310001288469us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001288469us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-12-310001288469us-gaap:AccumulatedTranslationAdjustmentMember2020-03-310001288469us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-03-310001288469us-gaap:MachineryAndEquipmentMembersrt:MinimumMember2020-01-012020-03-310001288469us-gaap:MachineryAndEquipmentMembersrt:MaximumMember2020-01-012020-03-310001288469mxl:MasksAndProductionEquipmentMembersrt:MinimumMember2020-01-012020-03-310001288469mxl:MasksAndProductionEquipmentMembersrt:MaximumMember2020-01-012020-03-310001288469us-gaap:LeaseholdImprovementsMembersrt:MinimumMember2020-01-012020-03-310001288469us-gaap:LeaseholdImprovementsMembersrt:MaximumMember2020-01-012020-03-310001288469us-gaap:MediumTermNotesMember2020-03-310001288469us-gaap:MediumTermNotesMember2019-12-310001288469us-gaap:MediumTermNotesMember2017-05-120001288469us-gaap:BaseRateMember2020-01-012020-03-310001288469us-gaap:FederalFundsEffectiveSwapRateMember2020-01-012020-03-310001288469us-gaap:PrimeRateMember2020-01-012020-03-310001288469mxl:OneTwoOrThreeMonthLondonInterbankOfferedRateLIBORMember2020-01-012020-03-310001288469mxl:LondonInterbankOfferedRateLIBORSubjecttoFloorMember2020-01-012020-03-31xbrli:pure00012884692017-05-122020-03-3100012884692017-05-1200012884692017-11-030001288469us-gaap:LondonInterbankOfferedRateLIBORMember2020-01-012020-03-310001288469us-gaap:DerivativeFinancialInstrumentsAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-03-310001288469us-gaap:DerivativeFinancialInstrumentsAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-3100012884692017-11-142020-03-310001288469mxl:EquityIncentivePlanMember2020-03-310001288469mxl:A2004EquityIncentivePlanMemberMember2020-03-310001288469mxl:ESPPMember2020-03-310001288469mxl:RestrictedStockUnitandRestrictedStockAwardMember2020-03-310001288469mxl:RestrictedStockUnitandRestrictedStockAwardMember2020-01-012020-03-310001288469us-gaap:PerformanceSharesMember2020-03-310001288469us-gaap:PerformanceSharesMember2020-01-012020-03-310001288469mxl:RestrictedStockUnitandRestrictedStockAwardMember2019-12-310001288469us-gaap:ShareBasedCompensationAwardTrancheThreeMember2020-01-012020-03-310001288469us-gaap:ShareBasedCompensationAwardTrancheOneMember2020-01-012020-03-310001288469us-gaap:ShareBasedCompensationAwardTrancheTwoMember2020-01-012020-03-310001288469us-gaap:PerformanceSharesMember2019-12-310001288469mxl:ESPPMember2020-01-012020-03-310001288469us-gaap:EmployeeStockMember2020-03-310001288469us-gaap:EmployeeStockMember2019-03-310001288469us-gaap:EmployeeStockMember2020-01-012020-03-310001288469us-gaap:EmployeeStockMember2019-01-012019-03-310001288469us-gaap:EmployeeStockOptionMember2019-12-310001288469us-gaap:EmployeeStockOptionMember2020-01-012020-03-310001288469us-gaap:EmployeeStockOptionMember2020-03-310001288469us-gaap:LatestTaxYearMember2020-01-012020-03-310001288469mxl:PreTaxReformTaxRateMemberMember2020-01-012020-03-310001288469mxl:CustomerADistributorMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-012020-03-310001288469mxl:CustomerBDirectMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-012020-03-310001288469mxl:CustomerBDirectMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2019-01-012019-03-310001288469us-gaap:AccountsReceivableMembermxl:CustomerBDirectMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-03-310001288469mxl:CustomerCMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-03-310001288469mxl:CustomerCMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2019-01-012019-12-310001288469us-gaap:SupplierConcentrationRiskMembermxl:VendorAMember2020-01-012020-03-310001288469us-gaap:SupplierConcentrationRiskMembermxl:VendorBMember2020-01-012020-03-310001288469us-gaap:SupplierConcentrationRiskMembermxl:VendorBMember2019-01-012019-03-310001288469us-gaap:SupplierConcentrationRiskMembermxl:VendorCMember2020-01-012020-03-310001288469us-gaap:SupplierConcentrationRiskMembermxl:VendorDMember2020-01-012020-03-310001288469us-gaap:SupplierConcentrationRiskMembermxl:VendorDMember2019-01-012019-03-310001288469us-gaap:SupplierConcentrationRiskMembermxl:VendorEMember2019-01-012019-03-310001288469srt:AsiaMemberus-gaap:SalesRevenueNetMember2020-01-012020-03-310001288469srt:AsiaMemberus-gaap:SalesRevenueNetMember2019-01-012019-03-310001288469country:USus-gaap:SalesRevenueNetMember2020-01-012020-03-310001288469country:USus-gaap:SalesRevenueNetMember2019-01-012019-03-310001288469us-gaap:SalesRevenueNetMembermxl:RestofWorldMember2020-01-012020-03-310001288469us-gaap:SalesRevenueNetMembermxl:RestofWorldMember2019-01-012019-03-310001288469us-gaap:SalesRevenueNetMember2020-01-012020-03-310001288469us-gaap:SalesRevenueNetMember2019-01-012019-03-310001288469country:HKus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-012020-03-310001288469country:HKus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2019-01-012019-03-310001288469country:CNus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2019-01-012019-03-310001288469country:USmxl:LonglivedassetsMember2020-01-012020-03-310001288469country:USmxl:LonglivedassetsMember2019-01-012019-12-310001288469country:SGmxl:LonglivedassetsMember2020-01-012020-03-310001288469country:SGmxl:LonglivedassetsMember2019-01-012019-12-310001288469mxl:LonglivedassetsMembermxl:RestofWorldMember2020-01-012020-03-310001288469mxl:LonglivedassetsMembermxl:RestofWorldMember2019-01-012019-12-310001288469mxl:LonglivedassetsMember2020-01-012020-03-310001288469mxl:LonglivedassetsMember2019-01-012019-12-310001288469mxl:ConnectedHomeMember2020-01-012020-03-310001288469mxl:ConnectedHomeMember2019-01-012019-03-310001288469mxl:ConnectedHomeMemberus-gaap:SalesRevenueNetMember2020-01-012020-03-310001288469mxl:ConnectedHomeMemberus-gaap:SalesRevenueNetMember2019-01-012019-03-310001288469mxl:InfrastructureMember2020-01-012020-03-310001288469mxl:InfrastructureMember2019-01-012019-03-310001288469mxl:InfrastructureMemberus-gaap:SalesRevenueNetMember2020-01-012020-03-310001288469mxl:InfrastructureMemberus-gaap:SalesRevenueNetMember2019-01-012019-03-310001288469mxl:IndustrialandmultimarketMember2020-01-012020-03-310001288469mxl:IndustrialandmultimarketMember2019-01-012019-03-310001288469mxl:IndustrialandmultimarketMemberus-gaap:SalesRevenueNetMember2020-01-012020-03-310001288469mxl:IndustrialandmultimarketMemberus-gaap:SalesRevenueNetMember2019-01-012019-03-310001288469mxl:RevenuefromDistributorsMember2020-01-012020-03-310001288469mxl:RevenuefromDistributorsMember2019-01-012019-03-310001288469us-gaap:AccountsReceivableMember2020-01-012020-03-310001288469us-gaap:AccountsReceivableMember2019-01-012019-12-310001288469srt:MinimumMember2020-03-310001288469srt:MaximumMember2020-03-310001288469us-gaap:InventoriesMember2020-03-310001288469us-gaap:OtherCommitmentsDomain2020-03-310001288469mxl:HomeGatewayPlatformDivisionOfIntelMemberus-gaap:SubsequentEventMember2020-04-052020-04-050001288469mxl:HomeGatewayPlatformDivisionOfIntelMemberus-gaap:SubsequentEventMember2020-04-050001288469us-gaap:SubsequentEventMember2020-04-052020-04-050001288469us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:SubsequentEventMember2020-04-052020-04-050001288469us-gaap:BaseRateMemberus-gaap:SubsequentEventMember2020-04-052020-04-05

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended March 31, 2020
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period From              to
Commission file number: 001-34666
MaxLinear Inc.
(Exact name of Registrant as specified in its charter)

Delaware14-1896129
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
5966 La Place Court, Suite 100,CarlsbadCalifornia92008
(Address of principal executive offices)(Zip Code)
(760) 692-0711
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stockMXLNew York Stock Exchange
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes     No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filerEmerging growth company
Non-accelerated filerSmaller reporting company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No   
As of April 22, 2020, the registrant had 72,356,711 shares of common stock, par value $0.0001, outstanding.


Table of Contents
MAXLINEAR, INC.
QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS

Page
Part I
Item 1.
Item 2.
Item 3.
Item 4.
Part II
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.


2

Table of Contents
PART I — FINANCIAL INFORMATION

3

Table of Contents
ITEM 1. FINANCIAL STATEMENTS

MAXLINEAR, INC.
CONSOLIDATED BALANCE SHEETS
(unaudited; in thousands, except par value amounts)
March 31,
2020
December 31,
2019
Assets
Current assets:
Cash and cash equivalents$98,373  $92,708  
Short-term restricted cash10  349  
Accounts receivable, net44,796  50,411  
Inventory31,088  31,510  
Prepaid expenses and other current assets6,342  6,792  
Total current assets180,609  181,770  
Long-term restricted cash57  60  
Property and equipment, net15,751  16,613  
Leased right-of-use assets9,864  10,978  
Intangible assets, net173,570  187,971  
Goodwill238,330  238,330  
Deferred tax assets73,492  67,284  
Other long-term assets1,752  2,785  
Total assets$693,425  $705,791  
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$13,597  $13,442  
Accrued price protection liability8,024  12,557  
Accrued expenses and other current liabilities30,661  31,171  
Accrued compensation10,146  9,392  
Total current liabilities62,428  66,562  
Long-term lease liabilities8,029  9,335  
Long-term debt207,197  206,909  
Other long-term liabilities7,614  8,065  
Total liabilities285,268  290,871  
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding    
Common stock, $0.0001 par value; 550,000 shares authorized; 72,345 shares issued and outstanding at March 31, 2020 and 71,931 shares issued and outstanding December 31, 20197  7  
Additional paid-in capital
539,035  529,596  
Accumulated other comprehensive loss(1,620) (887) 
Accumulated deficit
(129,265) (113,796) 
Total stockholders’ equity408,157  414,920  
Total liabilities and stockholders’ equity$693,425  $705,791  

See accompanying notes.
4

Table of Contents
MAXLINEAR, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited; in thousands, except per share data)

Three Months Ended March 31,
20202019
Net revenue$62,027  $84,635  
Cost of net revenue31,265  39,558  
Gross profit30,762  45,077  
Operating expenses:
Research and development25,689  27,399  
Selling, general and administrative24,632  23,591  
Impairment losses86    
Restructuring charges489  1,917  
Total operating expenses50,896  52,907  
Loss from operations(20,134) (7,830) 
Interest income225  147  
Interest expense(2,476) (2,975) 
Other income (expense), net180  (655) 
Total interest and other income (expense), net(2,071) (3,483) 
Loss before income taxes  (22,205) (11,313) 
Income tax benefit  (6,736) (6,462) 
Net loss$(15,469) $(4,851) 
Net loss per share:
Basic$(0.21) $(0.07) 
Diluted$(0.21) $(0.07) 
Shares used to compute net loss per share:
Basic72,039  69,968  
Diluted72,039  69,968  

See accompanying notes.
5

Table of Contents
MAXLINEAR, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(unaudited; in thousands)


Three Months Ended March 31,
20202019
Net loss$(15,469) $(4,851) 
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments, net of tax benefit of $9 and $1 for the three months ended March 31, 2020 and 2019, respectively(580) 513  
Unrealized loss on interest rate swap, net of tax benefit of $41 and $130 for the three months ended March 31, 2020 and 2019, respectively(153) (488) 
Other comprehensive income (loss)(733) 25  
Total comprehensive loss$(16,202) $(4,826) 


See accompanying notes.
6

Table of Contents
MAXLINEAR, INC.
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
THREE MONTHS ENDED MARCH 31, 2020
(unaudited; in thousands)
        
Common StockAdditional
Paid-In
Capital
Accumulated
Other
Comprehensive
Loss
Accumulated
Deficit
Total
Stockholders’
Equity
SharesAmount
Balance at December 31, 201971,931  $7  $529,596  $(887) $(113,796) $414,920  
Common stock issued pursuant to equity awards, net414  —  2,612  —  —  2,612  
Stock-based compensation—  —  6,827  —  —  6,827  
Other comprehensive loss—  —  —  (733) —  (733) 
Net loss—  —  —  —  (15,469) (15,469) 
Balance at March 31, 202072,345  $7  $539,035  $(1,620) $(129,265) $408,157  
See accompanying notes.

7

Table of Contents
MAXLINEAR, INC.
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
THREE MONTHS ENDED MARCH 31, 2019
(unaudited; in thousands)

Common StockAdditional
Paid-In
Capital
Accumulated
Other
Comprehensive
Income
Accumulated
Deficit
Total
Stockholders’
Equity
SharesAmount
Balance at December 31, 201869,551  $7  $493,287  $272  $(93,630) $399,936  
Common stock issued pursuant to equity awards, net981  —  5,615  —  —  5,615  
Stock-based compensation—  —  7,747  —  —  7,747  
Cumulative effect of adoption of new accounting principle—  —  —  —  (268) (268) 
Other comprehensive income—  —  —  25  —  25  
Net loss—  —  —  —  (4,851) (4,851) 
Balance at March 31, 201970,532  $7  $506,649  $297  $(98,749) $408,204  
See accompanying notes.

8

Table of Contents
MAXLINEAR, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited; in thousands)
Three Months Ended March 31,
20202019
Operating Activities
Net loss$(15,469) $(4,851) 
Adjustments to reconcile net loss to cash provided by operating activities:
Amortization and depreciation16,733  16,863  
Impairment losses86    
Amortization of debt issuance costs and accretion of discount on debt and leases410  402  
Stock-based compensation6,827  7,747  
Deferred income taxes(6,208) (6,476) 
Loss on disposal of property and equipment  35  
Impairment of leasehold improvements163  1,442  
Impairment of leased right-of-use assets44  2,182  
Gain on extinguishment of lease liabilities  (2,880) 
(Gain) loss on foreign currency(246) 567  
Excess tax deficiencies (benefits) on stock-based awards94  (1,737) 
Changes in operating assets and liabilities:
Accounts receivable5,615  (142) 
Inventory353  (1,015) 
Prepaid expenses and other assets1,443  604  
Leased right-of-use assets640  645  
Accounts payable, accrued expenses and other current liabilities(785) 1,921  
Accrued compensation3,361  893  
Accrued price protection liability(4,537) 2,489  
Lease liabilities(1,430) (2,125) 
Other long-term liabilities(446) (519) 
Net cash provided by operating activities6,648  16,045  
Investing Activities
Purchases of property and equipment(1,035) (2,155) 
Net cash used in investing activities(1,035) (2,155) 
Financing Activities
Repayment of debt  (15,000) 
Net proceeds from issuance of common stock488  2,628  
Minimum tax withholding paid on behalf of employees for restricted stock units(475) (4,419) 
Net cash provided by (used in) financing activities13  (16,791) 
Effect of exchange rate changes on cash and cash equivalents (303) 577  
Increase (decrease) in cash, cash equivalents and restricted cash5,323  (2,324) 
Cash, cash equivalents and restricted cash at beginning of period93,117  74,191  
Cash, cash equivalents and restricted cash at end of period$98,440  $71,867  
Supplemental disclosures of cash flow information:
Cash paid for interest$2,246  $3,099  
Cash paid for income taxes$557  $872  
Supplemental disclosures of non-cash activities:
Issuance of shares for payment of bonuses$2,599  $7,406  
See accompanying notes.
9

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

1. Organization and Summary of Significant Accounting Policies
Description of Business
MaxLinear, Inc. was incorporated in Delaware in September 2003. MaxLinear, Inc., together with its wholly owned subsidiaries, collectively referred to as MaxLinear, or the Company, is a provider of radio-frequency, or RF, high-performance analog, and mixed-signal communications system-on-chip solutions for the connected home, wired and wireless infrastructure, and industrial and multi-market applications. MaxLinear’s customers include electronics distributors, module makers, original equipment manufacturers, or OEMs, and original design manufacturers, or ODMs, who incorporate the Company’s products in a wide range of electronic devices, including cable DOCSIS broadband modems and gateways, wireline connectivity devices for in-home networking applications, RF transceivers and modems for wireless carrier access and backhaul infrastructure, fiber-optic modules for data center, metro, and long-haul transport networks, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products used in these and a range of other markets. The Company is a fabless integrated circuit design company whose products integrate all or a substantial portion of a broadband communication system.
Basis of Presentation and Principles of Consolidation
The accompanying unaudited consolidated financial statements include the accounts of MaxLinear, Inc. and its wholly owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. All intercompany transactions and investments have been eliminated in consolidation.
In the opinion of management, the Company’s unaudited consolidated interim financial statements contain adjustments, including normal recurring accruals necessary to present fairly the Company’s consolidated financial position, results of operations, comprehensive income (loss), stockholders’ equity, and cash flows.

The consolidated balance sheet as of December 31, 2019 was derived from the Company’s audited consolidated financial statements at that date. The accompanying unaudited consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2019 included in the Company’s Annual Report on Form 10-K filed by the Company with the Securities and Exchange Commission, or the SEC, on February 5, 2020, or the Annual Report. Interim results for the three months ended March 31, 2020 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2020.
Use of Estimates and Significant Risks and Uncertainties
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes to unaudited consolidated financial statements.

In the quarter ended March 31, 2020, the Company’s revenues declined relative to its prior expectations in part due to the impact of the novel coronavirus disease, or COVID-19, pandemic. In particular, the Company experienced customer requests to delay shipments and supply constraints attributable to the COVID-19 pandemic. Heightened volatility and uncertainty in customer demand and the worldwide economy in general has continued since March 31, 2020, and the Company may experience decreased sales and revenues in the near future. The Company’s management believes such impact may in particular affect the Company’s sales of high performance analog products in its industrial and multi-market business and may impact the rest of its business to some degree. However, the magnitude of such impact on the Company’s business and its duration is uncertain and cannot be reasonably estimated at this time.

The Company also believes that its $98.4 million of cash and cash equivalents at March 31, 2020 will be sufficient to fund its projected operating requirements for at least the next twelve months. A material adverse impact from COVID-19 could result in a need to raise additional capital or incur additional indebtedness to fund strategic initiatives or operating activities, particularly if the Company pursues additional acquisitions. The Company’s future capital requirements will depend on many factors, including the potential impact of the WiFi and Broadband assets business (Note 14) and the Company’s efforts to integrate that business, changes in revenue, the expansion of engineering, sales and marketing activities, the timing and extent
10

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
of expansion into new territories, the timing of introductions of new products and enhancements to existing products, the continuing market acceptance of the Company’s products and potential material investments in, or acquisitions of, complementary businesses, services or technologies. Additional funds may not be available on terms favorable to the Company or at all. If the Company is unable to raise additional funds when needed, it may not be able to sustain its operations or execute its strategic plans.

The Company is not aware of any specific event or circumstance that would require an update to its estimates or adjustments to the carrying value of its assets and liabilities as of April 29, 2020, the issuance date of this Quarterly Report on Form 10-Q. Actual results could differ from those estimates, particularly if the Company experiences material impacts from COVID-19.
Summary of Significant Accounting Policies
Refer to the Company’s Annual Report for a summary of significant accounting policies. On January 1, 2020, the Company adopted ASC Topic 326, Measurement of Credit Losses on Financial Instruments, or ASC 326, and accordingly, modified its policy on accounting for allowance for doubtful accounts on trade accounts receivable as stated below. As described under “Recently Adopted Accounting Pronouncements,” section below, the impact of adopting ASC 326 for the Company was not material.
There have been no other significant changes to the Company’s significant accounting policies during the three months ended March 31, 2020.
Accounts Receivable
The Company performs ongoing credit evaluations of its customers and assesses each customer’s credit worthiness. The Company monitors collections and payments from its customers and maintains an allowance for doubtful accounts based upon applying an expected credit loss rate to receivables based on the historical loss rate from similar high risk customers adjusted for current conditions, including any specific customer collection issues identified, and forecasts of economic conditions. Delinquent account balances are written off after management has determined that the likelihood of collection is remote. The allowance for credit losses as of March 31, 2020 and the activity in this account, including the current-period provision for expected credit losses for the three months ended March 31, 2020, were not material.
Recently Adopted Accounting Pronouncements
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, to replace the incurred loss methodology with an expected credit loss model that requires consideration of a broader range of information to estimate credit losses over the lifetime of the asset, including current conditions and reasonable and supportable forecasts in addition to historical loss information, to determine expected credit losses. Pooling of assets with similar risk characteristics and the use of a loss model are also required. Also, in April 2019, the FASB issued ASU No. 2019-04, Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, to clarify the inclusion of recoveries of trade receivables previously written off when estimating an allowance for credit losses. The amendments in this update are effective for the Company beginning with fiscal year 2020, including interim periods. The adoption of the amendments in this update as of January 1, 2020 did not have a material impact on the Company’s accounts receivable, net and accumulated deficit, as well as its results of operations for the three months ended March 31, 2020. The adoption is also not expected to have a material impact on the Company’s consolidated financial position and results of operations as of and for the year ending December 31, 2020.
In January 2017, the FASB issued ASU No. 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment, to simplify the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. An entity no longer will determine goodwill impairment by calculating the implied fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if the reporting unit had been acquired in a business combination. Instead, under the amendments in this update, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The Board also eliminated the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. The amendments in this update are effective for the Company beginning with fiscal year 2020, including interim periods. The Company performs its annual goodwill testing as of October 31, or more frequently if there are indicators of impairment. The application of the amendments in this update is not expected to have a material impact on the Company’s consolidated financial position and results of operations as of and for the
11

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
year ending December 31, 2020.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework— Changes to the Disclosure Requirements for Fair Value Measurement, to improve the fair value measurement reporting of financial instruments. The amendments in this update require, among other things, added disclosure of the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this update eliminate, among other things, disclosure of the reasons for and amounts of transfers between Level 1 and Level 2 for assets and liabilities that are measured at fair value on a recurring basis and an entity's valuation processes for Level 3 fair value measurements. The amendments in this update are effective for the Company beginning with fiscal year 2020. Retrospective application is required for all amendments in this update except the added disclosures, which should be applied prospectively. The adoption of the amendments in this update in the quarter ended March 31, 2020 did not have a material impact on the Company’s consolidated financial position and results of operations as of and for the three months ended March 31, 2020 and is also not expected to have a material impact on the Company’s consolidated financial position and results of operations as of and for the year ending December 31, 2020.

In August 2018, the FASB issued ASU No. 2018-15, Intangibles–Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract, to provide additional guidance on the accounting for costs of implementing cloud computing arrangements that are service contracts. The amendments in this update require the capitalization of implementation costs during the application development stage of such hosting arrangements and amortization of the expense over the term of the arrangement including any option to extend reasonably certain to be exercised or option to terminate reasonably certain not to be exercised. Capitalized implementation costs and amortization thereof are also required to be classified in the same line item in the statements of financial position, operations and cash flows associated with the hosting service fees. The amendments in this update are effective for the Company beginning with fiscal year 2020. The Company selected prospective application to all implementation costs incurred after the adoption date. The adoption of the amendments in this update did not have a material impact on the Company’s property and equipment, net and results of operations as of and for the three months ended March 31, 2020 and is also not expected to have a material impact on the Company’s consolidated financial position and results of operations as of and for the year ending December 31, 2020.

Recently Issued Accounting Pronouncements
In December 2019, the FASB issued ASU No. 2019-12 Income Taxes (Topic 740)—Simplifying the Accounting for Income Taxes, to remove certain exceptions and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. The amendments in this update will be effective for the Company beginning with fiscal year 2021, with early adoption permitted. Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The adoption of the amendments in this update is not expected to have a material impact on the Company’s consolidated financial position and results of operations.
2. Net Income (Loss) Per Share
Basic earnings per share, or EPS, is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted EPS is computed by dividing net income (loss) by the weighted-average number of common shares outstanding for the period and the weighted-average number of dilutive common stock equivalents outstanding for the period determined using the treasury-stock method. For purposes of this calculation, common stock options, restricted stock units and restricted stock awards are considered to be common stock equivalents and are only included in the calculation of diluted EPS when their effect is dilutive. In periods in which the Company has a net loss, dilutive common stock equivalents are excluded from the calculation of diluted EPS.
12

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
The table below presents the computation of basic and diluted EPS:
Three Months Ended March 31,
20202019
(in thousands, except per share amounts)
Numerator:
Net loss$(15,469) $(4,851) 
Denominator:
Weighted average common shares outstanding—basic72,039  69,968  
Dilutive common stock equivalents    
Weighted average common shares outstanding—diluted72,039  69,968  
Net loss per share:
Basic$(0.21) $(0.07) 
Diluted$(0.21) $(0.07) 
For the three months ended March 31, 2020 and 2019, the Company incurred net losses and accordingly excluded common stock equivalents for outstanding stock-based awards, which represented all potentially dilutive securities, of 3.3 million for the 2020 period and 2.9 million for the 2019 period, respectively, from the calculation of diluted net loss per share due to their anti-dilutive nature.

3. Restructuring Activity

From time to time, the Company approves and implements restructuring plans as a result of internal resource alignment and cost saving measures. Such restructuring plans include vacating certain leased facilities, terminating employees, and cancellation of contracts.

The following table presents the activity related to the restructuring plans, which is included in restructuring charges in the consolidated statements of operations:
Three Months Ended March 31,
20202019
(in thousands)
Employee separation expenses$44  $472  
Lease related charges275  1,345  
Other170  100  
$489  $1,917  

Lease related charges were related to exiting certain facilities. Lease-related charges for the three months ended March 31, 2019 includes the impairment of right-of-use assets of $2.2 million and leasehold improvements of $1.4 million, partially offset by a gain on the extinguishment of lease liabilities of $2.9 million following the release from such liability by the landlord. The Company does not expect to incur additional material costs related to current restructuring plans.
13

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

The following table presents a roll-forward of the Company's restructuring liability for the three months ended March 31, 2020. The restructuring liability is included in accrued expenses and other current liabilities and other long-term liabilities in the consolidated balance sheets.
Employee Separation ExpensesLease Related ChargesOtherTotal
(in thousands)
Liability as of December 31, 2019$  $818  $19  $837  
Restructuring charges44  275  170  489  
Cash payments(44) (72) (16) (132) 
Non-cash charges and adjustments  (208) (159) (367) 
Liability as of March 31, 2020  813  14  827  
Less: current portion as of March 31, 2020  (305) (14) (319) 
Long-term portion as of March 31, 2020$  $508  $  $508  

Remaining lease related charges as of March 31, 2020 primarily consist of common area maintenance obligations.
4. Goodwill and Intangible Assets

Goodwill

Goodwill arises from the acquisition method of accounting for business combinations and represents the excess of the purchase price over the fair value of the net assets and other identifiable intangible assets acquired. The fair values of net tangible assets and intangible assets acquired are based upon preliminary valuations and the Company’s estimates and assumptions are subject to change within the measurement period (potentially up to one year from the acquisition date).

During the three months ended March 31, 2020, there were no changes in the carrying amount of goodwill.

The Company performs an annual goodwill impairment assessment on October 31st each year, which effective in 2020, compares the fair value of each reporting unit, which the Company has determined to be the entity itself, with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds the carrying amount, the goodwill of the reporting unit is considered not impaired.

In addition to its annual review, the Company performs a test of impairment when indicators of impairment are present. During the three months ended March 31, 2020 and 2019, no goodwill impairment was recognized.
14

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Acquired Intangibles
Finite-lived Intangible Assets
The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases:
March 31, 2020December 31, 2019
Weighted
Average
Useful Life
(in Years)
Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying ValueAccumulated AmortizationNet Carrying Amount
(in thousands)
Licensed technology3.5$2,070  $(1,685) $385  $2,156  $(1,583) $573  
Developed technology6.9243,361  (117,103) 126,258  243,361  (108,522) 134,839  
Trademarks and trade names6.113,800  (7,076) 6,724  13,800  (6,511) 7,289  
Customer relationships4.6121,100  (80,897) 40,203  121,100  (75,847) 45,253  
Non-compete covenants3.01,100  (1,100)   1,100  (1,083) 17  
6.1$381,431  $(207,861) $173,570  $381,517  $(193,546) $187,971  

The following table sets forth amortization expense associated with finite-lived intangible assets, which is included in the consolidated statements of operations as follows:
Three Months Ended March 31,
20202019
(in thousands)
Cost of net revenue$8,591  $8,434  
Research and development1  34  
Selling, general and administrative5,723  5,798  
$14,315  $14,266  

Amortization of finite-lived intangible assets in cost of net revenue in the consolidated statements of operations results primarily from acquired developed technology.

The following table sets forth the activity related to finite-lived intangible assets:
Three Months Ended March 31,
20202019
(in thousands)
Beginning balance$187,971  $240,500  
Transfers to developed technology from IPR&D  1,500  
Amortization(14,315) (14,266) 
Impairment losses(86)   
Ending balance$173,570  $227,734  

The Company regularly reviews the carrying amount of its long-lived assets subject to depreciation and amortization, as well as the related useful lives, to determine whether indicators of impairment may exist that warrant adjustments to carrying values or estimated useful lives. An impairment loss is recognized when the sum of the expected future undiscounted net cash flows is less than the carrying amount of the asset. Should impairment exist, the impairment loss is measured based on the excess of the carrying amount of the asset over the asset’s fair value. During the three months ended March 31, 2020 and 2019, the Company recognized impairment losses related to finite-lived intangible assets of $0.1 million and $0, respectively.
15

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
The following table presents future amortization of the Company’s finite-lived intangible assets at March 31, 2020:
Amount
(in thousands)
2020 (9 months)$42,267  
202155,799  
202238,269  
202326,075  
202410,098  
Thereafter1,062  
Total$173,570  
Indefinite-lived Intangible Assets
Indefinite-lived intangible assets consisted entirely of acquired in-process research and development technology, or IPR&D. The following table sets forth the Company’s activities related to the indefinite-lived intangible assets:
Three Months Ended March 31,
20202019
(in thousands)
Beginning balance$  $4,400  
Transfers to developed technology from IPR&D  (1,500) 
Ending balance$  $2,900  

The Company performs its annual assessment of indefinite-lived intangible assets on October 31 each year or more frequently if events or changes in circumstances indicate that the asset might be impaired utilizing a qualitative test as a precursor to the quantitative test comparing the fair value of the assets with their carrying amount. Based on the qualitative test, if it is more likely than not that indicators of impairment exists, the Company proceeds to perform a quantitative analysis. During the three months ended March 31, 2020 and 2019, no indicators of impairment were identified and, as a result, no IPR&D impairment losses were recorded.

5. Financial Instruments
        The composition of financial instruments is as follows:
March 31, 2020December 31, 2019
(in thousands)
Liabilities
Interest rate swap$231  $37  
The fair value of the Company’s financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants and is recorded using a hierarchical disclosure framework based upon the level of subjectivity of the inputs used in measuring assets and liabilities. The levels are described below:
Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.
Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.
Level 3: Unobservable inputs are used when little or no market data is available.
16

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
The Company classifies its financial instrument within Level 2 of the fair value hierarchy on the basis of models utilizing market observable inputs. The interest rate swap has been valued on the basis of valuations provided by third-party pricing services, as derived from standard valuation or pricing models. Market-based observable inputs for the interest rate swap include one-month LIBOR-based yield curves over the term of the swap. The Company reviews third-party pricing provider models, key inputs and assumptions and understands the pricing processes at its third-party providers in determining the overall reasonableness of the fair value of its Level 2 financial instruments. The Company also considers the risk of nonperformance by assessing the swap counterparty’s credit risk in the estimate of fair value of the interest rate swap. As of March 31, 2020 and December 31, 2019, the Company has not made any adjustments to the valuations obtained from its third-party pricing providers. 
The following table presents a summary of the Company’s financial instruments that are measured on a recurring basis:
Fair Value Measurements
BalanceQuoted Prices
in Active Markets for Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
(in thousands)
Liabilities
Interest rate swap, March 31, 2020$231  $—  $231  $—  
Interest rate swap, December 31, 2019$37  $—  $37  $—  

The following table summarizes activity for the interest rate swap:
Three Months Ended
March 31,
2020
March 31,
2019
(in thousands)
Interest rate swap asset (liability)